In Situ Hybridisation Symposium 2013

Thursday, 10 October 2013

This is a Euroscicon Small Conference,  an outline of the day can be found at

In Situ Hybridisation Symposium 2013
Thursday, 10 October 2013 09:00 - 17:00

Cineworld: The O2
Peninsula Square
SE10 0DX
United Kingdom

Map and Directions

This technical workshop is dedicated to the discussion of in situ hybridisation (ISH), it's capabilites, difficulties and troubleshooting. This event will be an ideal place to network, establishing lines of communication for the future if you ever need help with setting up the  technique and giving you short cuts to improving your results. This event has CPD accreditation.

Why you should come:  This is a specialist meeting, with no other forum comparable internationally,  as it is rare to have so  many experts in the field, together in one room, giving you unrivalled access, all in one place.

Even experienced people who are interested in keeping up with the technique should be at this unique event.

Meeting Chair: Dr Julia Jones, Cancer Research UK, Cambridge

Who Should Attend: PhD students, postdocs, technicians and any scientists trying to set up ISH or already running it.

The Deadline for abstract submissions has now passed.

Talk times include 5 – 10 minutes for questions

9:00 – 9:45          Registration

9:45 – 10:00        Introduction by the Chair:  Dr Julia Jones, Cancer Research UK, Cambridge

10:00 – 10:30      Probe technology for in situ hybridisation

Dr James Howard Pringle,  Reader, University of Leicester , UK
In situ hybridization (ISH) is a powerful technique developed over 40 years ago for localizing specific nucleic acid targets within fixed tissues and cells and can provide temporal and spatial information about gene expression and genetic loci.  Although the technique of ISH has not the same prominence in the literature as immunohistochemistry, probe technology is currently improving and new clinically important applications are being developed.  In this talk I will compare different probe technologies for visualising RNA and DNA targets by in situ - fluorescence (FISH) and chromogenic (CISH) detection.  I will discuss target gene validation, probe design, sensitivity and the use of suitable control probes.  I will also highlight  the differences and the advantages of FISH and CISH probes in different applications.

10:30 – 11:00       In situ hybridisation and immunohistochemistry: better together or apart?

Dr Richard Poulsom, Head, Molecular Pathology Facility, Queen Mary, University of London, UK
Localising the expression of an mRNA and a protein can offer different views of what is happening within tissues, especially when the protein is secreted, or there is rapid movement and maturation of cells. Colocalisation is sometimes possible but at the expense of greatly reduced sensitivity. I will describe some of the strategies available to tackle this problem  and the related problem of localising DNA in situ together with specific epitopes defining the phenotype of cells.

11:00 – 11:30      Speakers’ photo then mid-morning break and poster exhibition and trade show

11:30 – 12:00      4-colour FISH probes in Prostate Cancer

Dr Jeremy Clark, SRA, University of East Anglia, UK
Androgen Receptor (AR) amplification in Prostate Cancer is associated with advanced treatment-resistant disease and death. Our work using 4-colour FISH probes has revealed the presence of AR gain and amplification in small clonal growths within a tumour field, highlighting the complexity of clonal variation in prostate cancer. Rehybridising the same tissue section with other FISH probes has enabled additional genomic changes in the same cells to be evaluated. This has revealed further divergent poor-prognosis clones in single prostates.

12:00  – 13:00     Lunch, poster exhibition and trade show


13:00 – 14:00      Question and Answer Session

14:00 – 14:30      Now you can see ANY RNA   

Dr Kai Wilkens, PhD MBA,  Advanced Cell Diagnostics, Inc
With RNAscope®, you can see any gene in any species, including non-coding RNA. With rapid probe design and universal assay workflows for any gene, RNAscope® Technology saves you precious time and effort, while delivering publication-quality data. The single-molecule detection sensitivity of RNAscope® in situ hybridization enables you to target low-expressing genes and even non-coding RNA, opening your research to new possibilities.

14:30 – 15:00      Afternoon Tea,  last poster session and trade show

15:00 – 15:30      High speed whole mount labeling technology

Mr Jacques Thélu, Flogentec Ltd, Scientist CNRS, University of Grenoble, France
Flogentec's innovative new device uses a patented process to subject multiple samples to a computer controlled flow of reactants. ISH or immunochemistry tests are carried out in situ on whole biological samples. The device ensures that solvents wash continuously through 3D samples at optimum conditions, maximizing the transfer of solvents to the specimens' core and by the way, reducing analytic lead time to 22 hours down from 3 days. Similarly, because it is a “stand alone” device, results are improved significantly. I will discuss some results, and techniques that can potentially be applied. FLO 400, the compact robot for the lab bench, is presented on the Flogentec’s stand.

15:30 – 16:00    Physical Approaches to Studying the Chromosomal Evolution of Anopheles darlingi and

Aedes aegypti

Dr Miriam Silva Rafael, Researcher and Teacher, INPA-Instituto Nacional de Pesquisas da Amazônia, Petrópolis, Brazil Anopheles darlingi is the main vector of malaria in the South America. The GST, actin, myosin, HSP70 and rDNA genes were physical mapped in the chromosomes of An. darlingi, which provide data for chromosomal homologies arm 3L in Anopheles gambiae, 2L in Anopheles stephensi, 3L in Anopheles funestus and 3R in Anopheles albimanus. We also studied the effect of semi-synthetic 1KL39-B and 1KL43-C dillapiol on Aedes aegypti as a potential control. Due to their high toxic and genotoxic effects, the two semi-synthetic can be considered a alternative for Ae. aegypti control. Funding: universal projects nos. 480926/2011-5 (FAPEAM) and 1036/2011 (CNPq).   


16:00 – 16:30      Multiplex in situ hybridisation to detect circulating tumour cells in breast cancer patients

Professor Raoul Charles Coombes, Professor of Medical Oncology, Imperial College, London, UK
The objectives of this study were to develop and characterise an ultrasensitive multiplex fluorescent RNA in situ hybridisation (ISH)-based CTC detection system called CTCscope.This method detects a multitude of tumour-specific markers at single-cell level in blood.CTCscope detected CTC transcripts of eight epithelial markers and three epithelial-mesenchymal-transition (EMT) markers for increased sensitivity. CTCscope was used to detect CTCs with minimal enrichment, and did not detect apoptotic or dead cells. In patient blood samples, CTCs detected by CellSearch, but not CTCscope, were positively correlated with CA15-3 levels. Circulating tumour cells detected by either CTCscope or CellSearch predicted PFS (CTCscope, HR (hazard ratio) 2.26, 95% CI 1.18–4.35,P.0.014; CellSearch, HR 2.50, 95% CI 1.27–4.90, P.0.008).

16:30 - 17:00        Chairman’s summing up and Close of Meeting

Keywords:   RNA, in situ hybridization, nucleic acid probes, non-isotopic labels, ISH, FISH, miRNA, 35S riboprobes, tyramide enhancement, miRNA detection, CISH,  FISH, DNA, breast cancer, IHC validation, RNAscope, digital pathology, gene expression, Hybridisation, Probe, automation, mRNA detection, antigen retrieval, DNA FISH, sequential detection, 4-colour FISH, prostate, GST, malaria, dillapiol extract, genotoxicity, dengue, in situ hybridiastion, breast cancer, CTC's, whole mount, ISH, immunochemistry, embryo, robot

Registration Web Site:


Contact Details

Payment Instructions

  • For enquiries regarding payment email:

    You can pay by - Credit card, Cheque, Purchase Order or Bank transfer.
    Payment must be received prior to the meeting

    Credit card
    You can pay during your online registration using your credit card. The information taken will be by secure server and we use Worldpay and PayPal for our credit card transactions. We always prefer debit cards for transactions, but can also take credit cards and American Express. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered

    Cheque Payment
    Cheques should be made payable to Euroscicon and mailed (together with a print out of the invoice which will be available at the end of the registration process).  After registration you will be emailed details of where to send your cheque.

    Purchase Order

    Please input your Purchase Order number in the box provided once you have selected your mode of payment and an invoice will be sent to you accordingly

    Bank transfer
    Clients organizing bank transfers from non-UK banks will need to pay an additional administration fee of £15.00. Please ensure that you add this fee onto your payment to ensure successful registration.  
    After registration you will be emailed details of where transfer your money.

        Linked in   
An event from European Scientific Conferences - Euroscicon "Specialising in communicating cutting edge technology & methodology in the Life Sciences"

EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address:  Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts. EN5 5SU, UK.  Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK 

© 2016
Quick, easy and affordable online event registration and event management software for all event sizes.